Vivanza Biosciences
Vivanza Biosciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Vivanza Biosciences
Start SIPVivanza Biosciences Investment Rating
-
Master Rating:
-
Vivanza Biosciences has an operating revenue of Rs. 30.95 Cr. on a trailing 12-month basis. An annual revenue growth of 63% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 14% is good. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 4 | 5 | 6 | 5 | 1 | 2 | 6 |
Operating Expenses Qtr Cr | 4 | 4 | 6 | 4 | 1 | 2 | 6 |
Operating Profit Qtr Cr | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Vivanza Biosciences Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹9.06
- 50 Day
- ₹10.08
- 100 Day
- ₹11.06
- 200 Day
- ₹11.97
- 20 Day
- ₹8.67
- 50 Day
- ₹10.34
- 100 Day
- ₹11.48
- 200 Day
- ₹12.72
Vivanza Biosciences Resistance and Support
Resistance | |
---|---|
First Resistance | 9.18 |
Second Resistance | 9.68 |
Third Resistance | 10.00 |
RSI | 41.40 |
MFI | 50.80 |
MACD Single Line | -0.70 |
MACD | -0.53 |
Support | |
---|---|
First Resistance | 8.36 |
Second Resistance | 8.04 |
Third Resistance | 7.54 |
Vivanza Biosciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 11,323 | 1,132,300 | 100 |
Week | 26,580 | 2,658,040 | 100 |
1 Month | 52,084 | 4,947,971 | 95 |
6 Month | 21,384 | 2,084,262 | 97.47 |
Vivanza Biosciences Result Highlights
Vivanza Biosciences Synopsis
BSE-Medical-Diversified
Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 14.21 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2023. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.Market Cap | 34 |
Sales | 20 |
Shares in Float | 0.21 |
No of funds | 2 |
Yield |
Book Value | 7.77 |
U/D Vol ratio | |
LTDebt / Equity | |
Alpha | 0.85 |
Beta | -0.62 |
Vivanza Biosciences
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 47.29% | 47.8% | 47.8% | 47.8% |
Financial Institutions/ Banks | ||||
Individual Investors | 6.23% | 5.66% | 5.65% | 5.67% |
Others | 46.48% | 46.54% | 46.55% | 46.53% |
Vivanza Biosciences Management
Name | Designation |
---|---|
Mr. Mehta J A | Managing Director |
Ms. A S Vyas | Independent Woman Director |
Mr. Parikh H A | Director |
Mr. Shah S D | Independent Director |
Vivanza Biosciences Forecast
Price Estimates
Vivanza Biosciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-10-26 | Quarterly Results | |
2023-08-10 | Quarterly Results | |
2023-06-30 | A.G.M. | Inter alia, to consider and approve the Directors Report and Secretarial Audit Report along with annexure for the Financial Year 2022-23. split from Rs. 10/- to Re. 1/-. |
2023-04-25 | Audited Results | |
2023-03-04 | Stock Split |
Date | Purpose | Remarks |
---|---|---|
2023-03-24 | Split | Rs.0.00 split from Rs. 10/- to Re. 1/-. |
Vivanza Biosciences FAQs
What is Share Price of Vivanza Biosciences ?
Vivanza Biosciences share price is ₹8 As on 09 December, 2023 | 08:02
What is the Market Cap of Vivanza Biosciences ?
The Market Cap of Vivanza Biosciences is ₹34.2 Cr As on 09 December, 2023 | 08:02
What is the P/E ratio of Vivanza Biosciences ?
The P/E ratio of Vivanza Biosciences is 30.8 As on 09 December, 2023 | 08:02
What is the PB ratio of Vivanza Biosciences ?
The PB ratio of Vivanza Biosciences is 8.4 As on 09 December, 2023 | 08:02